Concerning gastric cancer, amplifications of receptor tyrosine kinases of the ERBB family are observed in about 22% of gastric cancer patients (Bang et al, 2010), resulting in an activation of the downstream RAS pathway. The gene discussed is EGFR; the disease is gastric cancer.